This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Hearttransplantation is an effective treatment for end-stage heart disease, and postoperative patients' medication adherence is crucial for transplantation outcomes and long-term survival.
"Discover Advocate Children's Hospital's new pediatric hearttransplant program led by top doctors and certified by UNOS, in partnership with other top hospital
The Transplant Company recently announced that AlloSureis now commercially available for pediatric hearttransplant patients of all ages and patients who have received a simultaneous pancreas-kidney (SPK) transplant. 5 As with other organ transplants, the organs are at risk of rejection. Pediatr Transplant.
More than 4,500 hearttransplants were performed in the U.S. While the lifesaving operation improves the quality of life and longevity for most recipients, organ rejection remains a risk, with acute rejection occurring in up to 32% of recipients within the first year.
(MedPage Today) -- NBA champion and "Survivor" contestant Scot Pollard is "awake and feeling great" a day after a hearttransplant, his wife said Saturday on social media. Scot has a new heart!" Dawn Pollard posted Friday night on X, formerly.
(MedPage Today) -- The newborn that received the world's first partial hearttransplant in 2022 continued to do well a year later, according to a case report from the transplant team. Born with type A2 persistent truncus arteriosus and irreparable.
New York City-based NewYork-Presbyterian Morgan Stanley Children's Hospital performed the first "domino" hearttransplant on babies, according to an American Hospital Association report.
The world's first partial hearttransplant has achieved what researchers have spent more than a year hoping for—functioning valves and arteries that grow along with the young patient, as hypothesized by the pioneering team behind the procedure at Duke Health.
Advanced heart failure (AdvHF) can only be treated definitively by hearttransplantation (HTx), yet problems such right ventricle dysfunction (RVD), rejection, cardiac allograft vasculopathy (CAV), and primary graft dysfunction (PGD) are linked to a poor prognosis.
IntroductionThe objective of this study was to examine the impact of ventricular assist device support as a bridge to hearttransplantation in children with end-stage heart failure. Patients were divided into two groups: with pre transplant ventricular assist device (VAD) support and without VAD support.
In 2024, Boston-based Tufts Medical Center performed 70 adult hearttransplants, breaking its 2023 record by nine and setting the New England region record for the second year in a row.
Hearttransplant patients who live in socioeconomically disadvantaged areas are more likely to experience post-surgical complications and die within five years than patients who live in more advantaged areas, even when those patients were transplanted at topnotch high-volume hospitals.
based Northwell Health has received approval from the state health department to open a hearttransplant center at Cohen Children's Medical Center in Queens. New Hyde Park, N.Y.-based
Oklahoma City-based Oklahoma Children's Hospital is the first in the state to open a pediatric hearttransplant program, ABC affiliate KOCO reported March 5.
"Discover the incredible story of Bert Janssen, the Dutch man who has lived with a donor heart for 39 years and 252 days, officially confirmed as the world's lo
Despite developments in circulating biomarker and imaging technology in the assessment of cardiovascular disease, the surveillance and diagnosis of hearttransplant rejection has continued to rely on histopathologic interpretation of the endomyocardial biopsy.
Michelle Kittleson, MD, PhD, provides insight into the potential impact of a new risk score for hearttransplant allocation as well as the need for more equitable cardiovascular care in the US.
Despite being a hearttransplantation candidate, she declined revascularization and sought alternative treatments for angina, dyspnea, and daily activity limitations. EECP may alleviate the need for hearttransplantation through its integration as a standard early intervention.
Nearly a year after a newborn received the world's first partial hearttransplant, the transplanted valves and arteries are functioning well and growing along with the child's heart — a key measure of success in the procedure paving the way for future advancements.
Patients can develop de novo malignancies following orthotopic hearttransplantation. However, vascular tumors are not commonly described in this population.
Philadelphia-based University of Pennsylvania researchers found the number of hearttransplant emergency department visits increased with high admission rates but low in-hospital mortality rates.
The risk of early heart failure after hearttransplantation is lower if the donor heart is stored in a so-called heart-in-a-box instead of in the usual cooler with ice.
"Vanderbilt Transplant Center sets world record with 174 hearttransplants in 2024, including pediatric procedures. Learn more about their achievements and adva
When patients awaiting crucial hearttransplants are placed on the organ transplant waiting list, they've traditionally been arranged based on what type of treatments they were receiving for their current condition. But researchers from the University of Chicago have discovered a new, more accurate way to rank patients.
Researchers at Atlanta-based Emory University developed artificial intelligence that they say improves the prediction of successful hearttransplants by 10%.
A novel risk score developed by University of Chicago investigators outperformed conventional models in predicting death in hearttransplant candidates, which could help bring the field closer to optimal and equitable allocation.
A heart pump device the size of an AA battery could help children in need of a hearttransplant wait at home rather than the hospital, Science Daily reported May 7.
Continuing significant advancements in the field of xenotransplantation, surgeon-scientists from the University of Maryland School of Medicine provided an extensive analysis on the second patient in the world to receive a genetically-modified pig organ.
Introduction: Wellnest brings you , the latest medical news where an infant successfully received a partial hearttransplant! In a remarkable leap forward for pediatric cardiac care, a groundbreaking partial hearttransplant procedure has emerged as a beacon of hope for infants facing severe congenital heart conditions.
The outcome of hearttransplantation is significantly affected by perioperative infections. Individualised immunosuppression strategies are essential to reduce the risk of such infections.
A 53-year-old woman with the dilated phase of hypertrophic cardiomyopathy underwent orthotopic hearttransplantation. The donor heart was evaluated as normal preoperatively without mitral regurgitation or the.
In the United States, about 30-40% of donor hearts aren't considered for transplant due to inadequate function in the donor. This leads to a drop in the number of donated hearts that are available to be matched with someone who needs a hearttransplant.
Introduction Hearttransplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases.
The SHORE study confirms the superior performance of dual molecular testing, combining donor-derived cell-free DNA and gene-expression profiling for acute cellular rejection surveillance in optimizing care for hearttransplant patients.
Adult patients surviving with congenital heart disease (ACHD) is growing. We examine the factors associated with hearttransplant outcomes in this challenging population with complex anatomy requiring redo-sur.
Eosinophilic myocarditis (EM), a rare condition, is fatal if left untreated and has rarely been described in hearttransplant recipients. The cornerstone of treatment is corticosteroids, comprehensive therapy and heart failure management (including advanced mechanical support for fulminant myocarditis).
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content